Sign Up
OverviewAPI
Singapore struggles with recurring dengue outbreaks, necessitating a dengue vaccine. Challenges arise due to the complexities of the virus and the immune response. Existing vaccines like Dengvaxia, Qdenga, and TV003 offer protection against different virus serotypes. The article emphasizes the need for immediate action, drawing parallels with the deployment of COVID-19 vaccines.

Ask a question